Association of the trough, Peak/Trough ratio of Imatinib, pyridine–N-oxide imatinib and ABCG2 SNPs 34 G>A and SLCO1B3.T334G with Imatinib response in Egyptian Chronic Myeloid leukemia patients.

Citation:
Omran;, M. M., R. Abdelfatah;, H. Mousa;, N. Alieldin, and S. Shouman, "Association of the trough, Peak/Trough ratio of Imatinib, pyridine–N-oxide imatinib and ABCG2 SNPs 34 G>A and SLCO1B3.T334G with Imatinib response in Egyptian Chronic Myeloid leukemia patients. ", Frontier in Oncology Journal, vol. 10, 2020.